Renal Research Institute, New York, NY, USA.
Department of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nephrol Dial Transplant. 2018 Sep 1;33(9):1636-1642. doi: 10.1093/ndt/gfx271.
Cardiac disease is highly prevalent in hemodialysis (HD) patients. Decreased tissue perfusion, including cardiac, due to high ultrafiltration volumes (UFVs) is considered to be one of the drivers of cardiac dysfunction. While central venous oxygen saturation (ScvO2) is frequently used as an indicator of cardiac output in non-uremic populations, the relationship of ScvO2 and UFV in HD patients remains unclear. Our aim was to determine how intradialytic ScvO2 changes associate with UFV.
We conducted a 6-month retrospective cohort study in maintenance HD patients with central venous catheters as vascular access. Intradialytic ScvO2 was measured with the Critline monitor. We computed treatment-level slopes of intradialytic ScvO2 over time (ScvO2 trend) and applied linear mixed effects models to assess the association between patient-level ScvO2 trends and UFV corrected for body weight (cUFV).
We studied 6042 dialysis sessions in 232 patients. In about 62.4% of treatments, ScvO2 decreased. We observed in nearly 80% of patients an inverse relationship between cUFV and ScvO2 trend, indicating that higher cUFV is associated with steeper decline in ScvO2 during dialysis.
In most patients, higher cUFV volumes are associated with steeper intradialytic ScvO2 drops. We hypothesize that in a majority of patients the intradialytic cardiac function is fluid dependent, so that in the face of high ultrafiltration rates or volume, cardiac pre-load and consequently cardiac output decreases. Direct measurements of cardiac hemodynamics are warranted to further test this hypothesis.
心脏病在血液透析(HD)患者中非常普遍。由于超滤量(UFV)高,组织灌注减少,包括心脏,被认为是心脏功能障碍的驱动因素之一。虽然中心静脉血氧饱和度(ScvO2)经常被用作非尿毒症人群心输出量的指标,但 ScvO2 与 HD 患者 UFV 的关系仍不清楚。我们的目的是确定透析期间 ScvO2 的变化如何与 UFV 相关。
我们对使用中心静脉导管作为血管通路的维持性血液透析患者进行了为期 6 个月的回顾性队列研究。使用 Critline 监测仪测量透析期间的 ScvO2。我们计算了随时间变化的透析期间 ScvO2 的治疗水平斜率(ScvO2 趋势),并应用线性混合效应模型评估患者水平 ScvO2 趋势与体重校正超滤量(cUFV)之间的关系。
我们研究了 232 名患者的 6042 次透析。在大约 62.4%的治疗中,ScvO2 下降。我们观察到,在近 80%的患者中,cUFV 和 ScvO2 趋势之间存在反相关关系,这表明较高的 cUFV 与透析期间 ScvO2 下降幅度更大相关。
在大多数患者中,较高的 cUFV 与更陡峭的透析期间 ScvO2 下降相关。我们假设,在大多数患者中,透析期间的心脏功能是依赖于液体的,因此,在面对高超滤率或容量时,心脏前负荷和心输出量减少。需要直接测量心脏血流动力学来进一步检验这一假设。